Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TriSalus Life Sciences (TLSIW) Return on Equity (2022 - 2025)

TriSalus Life Sciences' Return on Equity history spans 4 years, with the latest figure at 1.29% for Q4 2025.

  • For Q4 2025, Return on Equity changed 0.0% year-over-year to 1.29%; the TTM value through Dec 2025 reached 1.29%, changed 0.0%, while the annual FY2025 figure was 1.31%, 18.0% up from the prior year.
  • Return on Equity reached 1.29% in Q4 2025 per TLSIW's latest filing, down from 1.72% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 6.32% in Q4 2023 to a low of 0.15% in Q4 2022.
  • Average Return on Equity over 4 years is 1.54%, with a median of 1.29% recorded in 2025.
  • Peak YoY movement for Return on Equity: surged 616bps in 2023, then crashed -502bps in 2024.
  • A 4-year view of Return on Equity shows it stood at 0.15% in 2022, then soared by 4016bps to 6.32% in 2023, then plummeted by -79bps to 1.3% in 2024, then fell by 0bps to 1.29% in 2025.
  • Per Business Quant, the three most recent readings for TLSIW's Return on Equity are 1.29% (Q4 2025), 1.72% (Q3 2025), and 1.16% (Q2 2025).